Upcoming Improvements to the GenomeQuest Engine

As the product manager at GenomeQuest, I'm very excited to tell you about a couple of really great new features in the GQ-Engine. Features that add to the growing library of high quality NGS components available to GQ platform developers and end users. Fast local alignments of NGS reads NGS read mappers typically align reads by trying to ...

“Genomic Chaos” Rapidly Advancing Cancer Research (Forbes)

Last week's Forbes article noted that George Sledge, the president of the American Society of Clinical Oncology (ASCO), told his colleagues to prepare for a new era in which rapidly advancing genetic technology will change the way cancer is treated for the better. Sledge said, we are entering an era of “genomic chaos,” a phrase that ...

Welcome Dr. Gerry Higgins

I have had the distinct pleasure of spending much time with Gerry Higgins during his consideration of an appointment at GenomeQuest.  With his wealth of leadership experience at NIH, pharma, and directly in the hospital arena, I have found him among the most knowledgeable, prepared, and committed scientists to the immediate and broad application of ...

WI Medical College Committed to Routine WGDx

This news is a couple months old but significant nonetheless in several aspects (keep in mind: this is where the blood-thinning drug warfarin was discovered): Highlights: Researchers at the Medical College of Wisconsin are taking pioneering steps to make whole-genome sequencing a standard part of diagnostic testing for children with rare inherited disorders not easily ...

The Future of Pathology in Personalized Medicine

Drs. Jeffrey Saffitz, Mark Boguski, and Peter Tonellato have put together a legendary two day invite-only session on the implications of genomics to the field of pathology and to health care at large. The real influencers in the field are here, from George Church to Eric Green to Rick ...

Battelle Report Calculates Nearly $1T Economic Return for US in Genomics

Battelle, the world’s largest independent R&D organization and one of the nation’s leading charitable trusts, yesterday released a comprehensive report on the US economic gains from genomics. Specifically, they calculated that genomics generated an economic impact of $796 billion (1988-2010) from about $6B in Fed. funding over those years.  Also, it generated ...

The Obstacles to Innovation in the Pharmaceutical Enterprise

I was recently asked by the Pistoia Alliance to comment on the following question in their blog: What do you see as the obstacles to innovation in the pharmaceutical industry? I was quite pleased by the request, as this is a topic in which I am personally compelled to participate. As the CEO of GenomeQuest, ...

NYT: Super-Computers Altering Science

Yes, Moore's Law is generating amazing hand devices but it's also powering the next generation of science.  As John Markoff says, so much so that the best researchers are framing big questions so that super-computers can work on big answers.  Nowhere is this more true than in comparative genomics where we're ...

JAMA Editorial: “Immediate Effect” of Whole Genome Sequencing on Cancer Treatment

The April 20, 2011 issue of the Journal of the American Medical Association, includes an editorial that speaks of the "remarkable" power of genomics for diagnosis of cancer.  Citing two patient examples, it argues that fundamental advances in cost and speed of whole-genome sequencing will likely make personalized genomic medicine for cancer treatment commonplace in ...

Clinical diagnostics using next-generation sequencing

On February 3, GenomeQuest announced the first ever integrated Whole Genome Analysis (WGA) software suite that incorporates a genetic diagnostic panel. In concert with the great work done by Dr. Roberta Pagon and the hundreds of GeneReviews authors who have created the authoritative registry of genetic tests available, we can now run every ...